FDA Approves New Labeling For ISENTRESS® To Include 96-Week Efficacy And Tolerability Data In Adult Patients Infected With HIV-1

Friday, August 6th, 2010

Merck announced today that the U.S. Food and Drug Administration (FDA) has approved a labeling update for ISENTRESS® (raltegravir) tablets to include 96-week data, which demonstrates the durable efficacy of ISENTRESS in HIV-1 infected patients. ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection ...

GOP Sens. Request Assurances From HHS That High-Risk Pools Won’t Include Abortion Coverage

Friday, July 30th, 2010

In a letter sent on Wednesday, 13 Republican senators asked HHS Secretary Kathleen Sebelius for assurances that the new high-risk insurance pools will not provide coverage for abortion services, CQ HealthBeat reports. The insurance pools set up under the federal health reform law (PL 111-148) aim to provide coverage to ...

Updated Alzheimer’s Diagnostic Criteria To Include Earlier Stages And Biomarkers

Thursday, July 15th, 2010

Following recommendations by expert groups in the US, criteria for diagnosing Alzheimer's disease, which have not changed in the last 25 years, will be updated to reflect scientific advances; the new guidelines will cover earlier stages and biomarkers of the disease. A workgroup of the US National Institute ...

Indiana Network For Patient Care Expanding To Include Post-Acute Care Facilities

Sunday, June 13th, 2010

The Indiana Network for Patient Care (INPC), one of the highest volume health information exchanges in the United States, is expanding to include post-acute care facilities, bringing the benefits of secure health information exchange to a growing number of individuals who often have significant health care needs... Find more info about ...

Alli and Xenical Revise Safety Labels to Include Liver-Injury Warnings

Wednesday, May 26th, 2010

Last year HealthNews reported that liver injuries were linked to orlistat, a weight-loss drug marketed under the popular brands Alli and Xenical. Today the FDA announced that it will require liver-injury warnings on both these medications. read more Find more info about Alli and Xenical Revise Safety Labels to Include Liver-Injury Warnings ...